Dr. Michael Tamilia is not included in the author byline. He should be listed as the third author and affiliated with Lady Davis Institute for Medical Research-Jewish General Hospital; Montreal, QC, Canada and Division of Endocrinology, Jewish General Hospital; Montreal, QC, Canada. The contributions of this author are as follows: Dr. Tamilia was involved in the very early process of the work describe in the paper, in both discussions and experimental design.
Reference
- 1.Dotan I, Roche PJR, Paliouras M, Mitmaker EJ, Trifiro MA (2016) Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells. PLoS ONE 11(2): e0149723 doi:10.1371/journal.pone.0149723 [DOI] [PMC free article] [PubMed] [Google Scholar]